New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 8, 2014
09:00 EDTENDP, BDSIBioDelivery Sciences still a takeover target, says Janney Capital
Janney Capital continues to believe that BioDelivery Sciences (BDSI) could be a takeover target, noting that it thinks partner Endo International (ENDP) could be a potential buyer if BioDelivery has more positive top-line results and if the market weakens. The firm, which added that it likes BioDelivery Sciences as a stand-alone company as well, maintains its Buy rating and $15 fair value estimate on the stock.
News For BDSI;ENDP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 2, 2015
17:14 EDTBDSIBioDelivery Sciences files $150M mixed securities shelf
Subscribe for More Information
10:48 EDTBDSIOptions with increasing implied volatility
Subscribe for More Information
July 1, 2015
18:39 EDTBDSIOn The Fly: After Hours Movers
UP AFTER EARNINGS: Progress Software (PRGS), up 6.6%. ALSO HIGHER: Xoom (XOOM), up 22% after announcing company to be acquired by PayPal... BioDelivery Sciences (BDSI), up 4.7% after Point72 Asset Management reports 5.5% passive stake in the company... Green Brick Partners (GRBK), up 7.5% after Third Point reports 16.9% stake in the company.
16:13 EDTBDSIPoint72 Asset Management reports 5.5% passive stake in BioDelivery Sciences
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use